The International Computerized System Validation Congress (ICSVC) is the first European Congress dedicated to the Validation of Computerized Systems for Pharma, Biotech and MedTech Industries. Through this international congress we will explore the importance of computerized system validation for companies operating in these critical sectors.
With the increasing digitalization of the Pharmaceutical, Biotechnology and Medical Devices industries, computerized systems are playing an increasingly crucial role in the collection, analysis, and management of critical data. However, with the increasing complexity of these systems, validating their performance and regulatory compliance has become a major challenge for companies.
The ICSVC aims to provide key information on relevant standards and regulations, as well as best practices for computerized system validation, to help companies ensure the quality and safety of their products.
The International Computerized System Validation Congress (ICSVC) is to be the European leading platform for knowledge sharing and experience exchange among Pharmaceutical, Biotechnology and Medical devices industries professionals regarding computerized system validation.
We aim to bring together experts from around the world to discuss the latest trends, challenges, solutions, and best practices in computerized system validation. We hope to encourage participants to explore the latest regulations and standards to maintain regulatory compliance, share examples of successful computerized system validation, and discover innovative tools and technologies to enhance computerized system validation (e.g., Agile methodology, Software tools, Machine Learning, AI, SaaS, AIaMD etc.)
We believe that our congress will provide a forum for participants to connect, establish relationships, and share knowledge with peers from around the world. We also aim to inspire participants to adopt a proactive approach to computerized system validation, to ensure that products in Pharmaceutical, Biotechnology and Medical Devices industries are safe, effective, and compliant with current regulations.
Through a combination of expert presentations, interactive workshops, and case studies, we aim to offer a dynamic and engaging learning experience for all participants, regardless of their level of experience in computerized system validation. We believe that this approach will enable all participants, including start-ups, scale-up, and spin-offs, to derive maximum benefit from the Congress and to build strong connections with peers and industry experts.
To facilitate knowledge sharing and support lifelong learning, academic and professional training organizations will be a major actor of this Congress. These organizations will provide expert insights and guidance on the latest developments in computerized system validation, as well as the most effective learning methodologies and pedagogical approaches.
ICSVC is committed to providing a collaborative and inclusive environment where participants can share their experiences, knowledge, and ideas, and establish lasting relationships with peers from around the world.
You will be the principal actor of this congress.
Our mission is also to support start-ups, scale-ups, and spin-offs in developing and implementing innovation through implementing effective computerized system strategies, which meet regulatory requirements and adhere to the highest standards of safety and efficacy. We are committed to providing a dynamic and interactive learning environment where participants can acquire the knowledge and skills needed to succeed in an increasingly competitive and constantly evolving industry.
Finally, our mission is to support the continued growth and development of the Pharmaceutical, Biotechnology and Medical Devices industries by facilitating collaboration and communication among key stakeholders. We believe that promoting knowledge, expertise, and innovation in computerized system validation is essential for addressing future challenges, ensuring the safety and efficacy of healthcare products, and improving the quality of life for patients around the world.
